SCHEMBL8322396

SCHEMBL8322396

CN(C)C([CH]c1cccc(C(F)(F)F)c1)Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.46
HTR2B P41595 2/20 0.46
HTR2C P28335 1/20 0.46
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
ACP3 P15309 1/20 0.43
SIGMAR1 Q99720 2/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
NFE2L2 Q16236 1/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
ADRA2C P18825 1/20 0.41
SLC6A4 P31645 1/20 0.41
ADRA1A P35348 1/20 0.41
DRD3 P35462 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8322987 0.85 NPC1 (0.52) HTR2AHTR2BHTR2CPPARGPPARA
SCHEMBL8324481 0.82 NFE2L2 (0.45) PPARGPPARASIGMAR1CYP1A2CYP3A4
SCHEMBL8320387 0.82 HTR2A (0.53) HTR2AHTR2BHTR2CPPARGPPARA
SCHEMBL8324682 0.80 TP53 (0.40) HTR2APPARGPPARASIGMAR1TP53
SCHEMBL8327755 0.79 PNMT (0.41) SIGMAR1TSHRGRIN1GRIN2BNPC1
SCHEMBL8326976 0.79 MAOB (0.45) HTR2ASIGMAR1CYP2D6MAPTADRA2C
SCHEMBL8326920 0.78 HTR2A (0.46) HTR2AHTR2BHTR2CPPARGPPARA
SCHEMBL8324959 0.78 SIGMAR1 (0.39) HTR2ASIGMAR1ADRA2CSLC6A4ADRA1A
SCHEMBL24305725 0.74 NFE2L2 (0.41) HTR2AHTR2BHTR2CPPARGPPARA
SCHEMBL8323592 0.74 NOS3 (0.40) HTR2APPARGPPARASIGMAR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0948496-A2 SUBSTITUTED PYRIMIDINONE AND PYRIDONE COMPOUNDS AND METHODS OF USE Amgen inc. (US) 1999-10-13 EP disclosed
WO-1998024780-A2 SUBSTITUTED PYRIMIDINONE AND PYRIDINONE COMPOUNDS AND THEIR USE AMGEN INC. (US) 1998-06-11 WO disclosed